{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:22:27Z","timestamp":1793024547328,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T00:00:00Z","timestamp":1726358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82,101,338"],"award-info":[{"award-number":["82,101,338"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82,171,424"],"award-info":[{"award-number":["82,171,424"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.bbi.2024.09.022","type":"journal-article","created":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T17:58:06Z","timestamp":1726423086000},"page":"229-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Astrocyte-neuron communication through the complement C3-C3aR pathway in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"123","author":[{"given":"Xiaosa","family":"Chi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkai","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongjie","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2024.09.022_b0005","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/glia.23757","article-title":"Activated microglia desialylate their surface, stimulating complement receptor 3-mediated phagocytosis of neurons","volume":"68","author":"Allendorf","year":"2020","journal-title":"Glia"},{"key":"10.1016\/j.bbi.2024.09.022_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25020817","article-title":"The Importance of Complement-Mediated Immune Signaling in Alzheimer's Disease Pathogenesis","volume":"25","author":"Batista","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bbi.2024.09.022_b0015","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12016-010-8242-y","article-title":"Immunology, autoimmunity, and autoantibodies in Parkinson's disease","volume":"42","author":"Benkler","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.bbi.2024.09.022_b0020","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.bbi.2021.04.003","article-title":"Astrocytic Kir6.1 deletion aggravates neurodegeneration in the lipopolysaccharide-induced mouse model of Parkinson's disease via astrocyte-neuron cross talk through complement C3\u2013C3R signaling","volume":"95","author":"Chen","year":"2021","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.bbi.2024.09.022_b0025","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/cdd.2014.179","article-title":"GSK-3\u03b2 dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and \u03b1-synuclein","volume":"22","author":"Credle","year":"2015","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.bbi.2024.09.022_b0030","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/(SICI)1098-1136(199905)26:3<201::AID-GLIA2>3.0.CO;2-M","article-title":"Receptor for the C3a anaphylatoxin is expressed by neurons and glial cells","volume":"26","author":"Davoust","year":"1999","journal-title":"Glia"},{"key":"10.1016\/j.bbi.2024.09.022_b0035","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.autrev.2016.07.022","article-title":"Parkinson's disease: autoimmunity and neuroinflammation","volume":"15","author":"De Virgilio","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.bbi.2024.09.022_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2018.10.014","article-title":"Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies","volume":"100","author":"Dejanovic","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.bbi.2024.09.022_b0045","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jneuroim.2011.05.006","article-title":"Upregulation of microglial C1q expression has no effects on nigrostriatal dopaminergic injury in the MPTP mouse model of Parkinson disease","volume":"236","author":"Depboylu","year":"2011","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.bbi.2024.09.022_b0050","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12974-018-1171-z","article-title":"Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration","volume":"15","author":"Duffy","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2024.09.022_b0055","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1096\/fj.08-120410","article-title":"Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models","volume":"23","author":"Duka","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.bbi.2024.09.022_b0060","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/cr.2009.139","article-title":"Complement and its role in innate and adaptive immune responses","volume":"20","author":"Dunkelberger","year":"2010","journal-title":"Cell Res"},{"key":"10.1016\/j.bbi.2024.09.022_b0065","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/glia.22437","article-title":"Toll-like receptor 4 is required for \u03b1-synuclein dependent activation of microglia and astroglia","volume":"61","author":"Fellner","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.bbi.2024.09.022_b0070","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12974-017-0814-9","article-title":"Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain","volume":"14","author":"Fonseca","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2024.09.022_b0075","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.2174\/1570159X22666231017141636","article-title":"Inflammation, Autoimmunity and Neurodegenerative Diseases","volume":"22","author":"Garmendia","year":"2024","journal-title":"Therapeutics and beyond. Curr Neuropharmacol"},{"key":"10.1016\/j.bbi.2024.09.022_b0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.phrs.2015.03.010","article-title":"Glycogen synthase kinase-3 beta (GSK-3\u03b2) signaling: implications for Parkinson's disease","volume":"97","author":"Golpich","year":"2015","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.bbi.2024.09.022_b0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12974-021-02225-9","article-title":"Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity","volume":"18","author":"Gregersen","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2024.09.022_b0090","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/mds.27718","article-title":"The A1 astrocyte paradigm: New avenues for pharmacological intervention in neurodegeneration","volume":"34","author":"Hinkle","year":"2019","journal-title":"Movement Disorders : Official Journal of the Movement Disorder Society"},{"key":"10.1016\/j.bbi.2024.09.022_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105349","article-title":"Expression of transduced nucleolin promotes the clearance of accumulated \u03b1-synuclein in rodent cells and animal model","volume":"154","author":"Ho","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbi.2024.09.022_b0100","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.redox.2017.09.017","article-title":"Complement receptor 3 mediates NADPH oxidase activation and dopaminergic neurodegeneration through a Src-Erk-dependent pathway","volume":"14","author":"Hou","year":"2018","journal-title":"Redox Biol"},{"key":"10.1016\/j.bbi.2024.09.022_b0105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejphar.2019.02.020","article-title":"Complement C3a receptor antagonist attenuates tau hyperphosphorylation via glycogen synthase kinase 3\u03b2 signaling pathways","volume":"850","author":"Hu","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbi.2024.09.022_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104653","article-title":"Reprogramming astrocytic NDRG2\/NF-\u03baB\/C3 signaling restores the diabetes-associated cognitive dysfunction","volume":"93","author":"Jiang","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbi.2024.09.022_b0115","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.4049\/jimmunol.1900494","article-title":"Size-Selective Phagocytic Clearance of Fibrillar \u03b1-Synuclein through Conformational Activation of Complement Receptor 4","volume":"204","author":"Juul-Madsen","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.bbi.2024.09.022_b0120","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","article-title":"Signaling to NF-kappaB by Toll-like receptors","volume":"13","author":"Kawai","year":"2007","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.bbi.2024.09.022_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105313","article-title":"Complement system changes in blood in Parkinson's disease and progressive Supranuclear Palsy\/Corticobasal Syndrome","volume":"108","author":"Khosousi","year":"2023","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.bbi.2024.09.022_b0130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13024-018-0276-2","article-title":"Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating \u03b1-synuclein transmission and neuroinflammation","volume":"13","author":"Kim","year":"2018","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.bbi.2024.09.022_b0135","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12974-022-02494-y","article-title":"The circadian clock protein Rev-erb\u03b1 provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome","volume":"19","author":"Kou","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2024.09.022_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.956440","article-title":"Worldwide trends in mortality related to Parkinson's disease in the period of 1994\u20132019: analysis of vital registration data from the WHO Mortality Database","volume":"13","author":"Lampropoulos","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bbi.2024.09.022_b0145","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41531-022-00352-5","article-title":"Melatonin ameliorates Parkinson's disease via regulating microglia polarization in a ROR\u03b1-dependent pathway","volume":"8","author":"Li","year":"2022","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.bbi.2024.09.022_b0150","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuron.2014.11.018","article-title":"NF\u03baB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer's disease","volume":"85","author":"Lian","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.bbi.2024.09.022_b0155","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1523\/JNEUROSCI.2117-15.2016","article-title":"Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease","volume":"36","author":"Lian","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2024.09.022_b0160","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.brainres.2007.08.033","article-title":"Complement 3-deficient mice are not protected against MPTP-induced dopaminergic neurotoxicity","volume":"1178","author":"Liang","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2024.09.022_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2018.10.031","article-title":"Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer's Disease","volume":"100","author":"Litvinchuk","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.bbi.2024.09.022_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154756","article-title":"Dihydromyricetin attenuates intracerebral hemorrhage by reversing the effect of LCN2 via the system Xc- pathway","volume":"115","author":"Liu","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbi.2024.09.022_b0175","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1289\/ehp.6361","article-title":"Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation","volume":"111","author":"Liu","year":"2003","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.bbi.2024.09.022_b0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1742-2094-3-29","article-title":"Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study","volume":"3","author":"Loeffler","year":"2006","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2024.09.022_b0185","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.bbi.2024.09.022_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2023.12.003","article-title":"Clearance of \u03b2-amyloid and synapses by the optogenetic depolarization of microglia is complement selective","volume":"112","author":"Lv","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.bbi.2024.09.022_b0195","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1021\/acs.jproteome.0c01002","article-title":"Complement and Coagulation Cascades are Potentially Involved in Dopaminergic Neurodegeneration in \u03b1-Synuclein-Based Mouse Models of Parkinson's Disease","volume":"20","author":"Ma","year":"2021","journal-title":"J Proteome Res"},{"key":"10.1016\/j.bbi.2024.09.022_b0200","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrd4657","article-title":"Complement, a target for therapy in inflammatory and degenerative diseases","volume":"14","author":"Morgan","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bbi.2024.09.022_b0205","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neulet.2008.10.104","article-title":"Glycogen synthase kinase-3beta is associated with Parkinson's disease","volume":"449","author":"Nagao","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbi.2024.09.022_b0210","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1021\/acschemneuro.2c00019","article-title":"Fibrinogen and Complement Factor H Are Promising CSF Protein Biomarkers for Parkinson's Disease with Cognitive Impairment\u2500A Proteomics-ELISA-Based Study","volume":"13","author":"Naskar","year":"2022","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.bbi.2024.09.022_b0215","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12868-015-0192-0","article-title":"Exogenous \u03b1-synuclein induces toll-like receptor 4 dependent inflammatory responses in astrocytes","volume":"16","author":"Rannikko","year":"2015","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.bbi.2024.09.022_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115496","article-title":"GSK-3\u03b2: an exuberating neuroinflammatory mediator in Parkinson's disease","volume":"210","author":"Samim Khan","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bbi.2024.09.022_b0225","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/s12974-020-02024-8","article-title":"The good, the bad, and the opportunities of the complement system in neurodegenerative disease","volume":"17","author":"Schartz","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2024.09.022_b0230","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf6295","article-title":"Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP\/PS1 mice","volume":"9","author":"Shi","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bbi.2024.09.022_b0235","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1002\/alz.13734","article-title":"Subsequent correlated changes in complement component 3 and amyloid beta oligomers in the blood of patients with Alzheimer's disease","volume":"20","author":"Shim","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbi.2024.09.022_b0240","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","article-title":"The classical complement cascade mediates CNS synapse elimination","volume":"131","author":"Stevens","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bbi.2024.09.022_b0245","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/cns.12721","article-title":"Thioredoxin-interacting protein induced \u03b1-synuclein accumulation via inhibition of autophagic flux: implications for Parkinson's disease","volume":"23","author":"Su","year":"2017","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.bbi.2024.09.022_b0250","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature22815","article-title":"T cells from patients with Parkinson's disease recognize \u03b1-synuclein peptides","volume":"546","author":"Sulzer","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2024.09.022_b0255","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4049\/jimmunol.1901068","article-title":"Complement-Mediated Events in Alzheimer's Disease: mechanisms and Potential Therapeutic Targets","volume":"204","author":"Tenner","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.bbi.2024.09.022_b0260","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/nprot.2014.143","article-title":"Addition of exogenous \u03b1-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous \u03b1-synuclein to Lewy body and Lewy neurite-like aggregates","volume":"9","author":"Volpicelli-Daley","year":"2014","journal-title":"Nat Protoc"},{"key":"10.1016\/j.bbi.2024.09.022_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2022.156027","article-title":"The pyrethroids metabolite 3-phenoxybenzoic acid induces dopaminergic degeneration","volume":"838","author":"Wan","year":"2022","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.bbi.2024.09.022_b0270","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.neuropharm.2007.03.017","article-title":"Inhibition of glycogen synthase kinase-3beta protects dopaminergic neurons from MPTP toxicity","volume":"52","author":"Wang","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2024.09.022_b0275","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.ajpath.2011.01.006","article-title":"Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy","volume":"178","author":"Wang","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbi.2024.09.022_b0280","doi-asserted-by":"crossref","DOI":"10.1111\/ejn.13956","article-title":"\u03b1-Synuclein activates innate immunity but suppresses interferon-\u03b3 expression in murine astrocytes","author":"Wang","year":"2018","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bbi.2024.09.022_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2023.115550","article-title":"Complement receptor 3-mediated neurotoxic glial activation contributes to rotenone-induced cognitive decline in mice","volume":"266","author":"Wang","year":"2023","journal-title":"Ecotoxicol Environ Saf"},{"key":"10.1016\/j.bbi.2024.09.022_b0290","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40035-021-00265-y","article-title":"Astrocyte dysfunction in Parkinson's disease: from the perspectives of transmitted \u03b1-synuclein and genetic modulation","volume":"10","author":"Wang","year":"2021","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.bbi.2024.09.022_b0295","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/glia.23955","article-title":"The complement C3\u2013C3aR pathway mediates microglia-astrocyte interaction following status epilepticus","volume":"69","author":"Wei","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.bbi.2024.09.022_b0300","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.expneurol.2010.06.017","article-title":"Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia","volume":"225","author":"Wills","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbi.2024.09.022_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109646","article-title":"Complement C1q drives microglia-dependent synaptic loss and cognitive impairments in a mouse model of lipopolysaccharide-induced neuroinflammation","volume":"237","author":"Wu","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2024.09.022_b0310","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1093\/brain\/awab122","article-title":"Reactive microglia enhance the transmission of exosomal \u03b1-synuclein via toll-like receptor 2","volume":"144","author":"Xia","year":"2021","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.bbi.2024.09.022_b0315","doi-asserted-by":"crossref","first-page":"23527","DOI":"10.1038\/srep23527","article-title":"Inhibition of Glycogen Synthase Kinase-3beta (GSK-3beta) as potent therapeutic strategy to ameliorates L-dopa-induced dyskinesia in 6-OHDA parkinsonian rats","volume":"6","author":"Xie","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.bbi.2024.09.022_b0320","doi-asserted-by":"crossref","first-page":"1241750","DOI":"10.3389\/fnagi.2023.1241750","article-title":"The \u03b3-Adducin 1\u2013357 fragment promotes tau pathology","volume":"15","author":"Yu","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.bbi.2024.09.022_b0325","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/mds.29181","article-title":"Fine Particulate Matter Triggers \u03b1-Synuclein Fibrillization and Parkinson-like Neurodegeneration","volume":"37","author":"Yuan","year":"2022","journal-title":"Movement Disorders : Official Journal of the Movement Disorder Society"},{"key":"10.1016\/j.bbi.2024.09.022_b0330","doi-asserted-by":"crossref","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","article-title":"An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex","volume":"34","author":"Zhang","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2024.09.022_b0335","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainresbull.2016.11.004","article-title":"Effects of dimethyl sulfoxide on the morphology and viability of primary cultured neurons and astrocytes","volume":"128","author":"Zhang","year":"2017","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbi.2024.09.022_b0340","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41419-023-05807-y","article-title":"Cntnap4 partial deficiency exacerbates \u03b1-synuclein pathology through astrocyte-microglia C3\u2013C3aR pathway","volume":"14","author":"Zhang","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbi.2024.09.022_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2024.102654","article-title":"Astrocyte-secreted C3 signaling impairs neuronal development and cognition in autoimmune diseases","volume":"240","author":"Zhu","year":"2024","journal-title":"Prog Neurobiol"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159124006251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159124006251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:28:28Z","timestamp":1778761708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159124006251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":69,"alternative-id":["S0889159124006251"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2024.09.022","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Astrocyte-neuron communication through the complement C3-C3aR pathway in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2024.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}